| Julie E Allen, PHARM D | |
|
452 Market St, Colusa, CA 95932-2424 | |
| (530) 219-8496 | |
| (530) 458-3202 |
| Full Name | Julie E Allen |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 452 Market St, Colusa, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1598979924 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 39270 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Julie E Allen, PHARM D 452 Market St, Colusa, CA 95932-2424 Ph: (530) 219-8496 | Julie E Allen, PHARM D 452 Market St, Colusa, CA 95932-2424 Ph: (530) 219-8496 |
News Archive
Today, President Obama and Congressional Democrats accomplished something that has eluded Presidents, Congress and the American people for decades. After a year of hard work, we have passed health insurance reform. We owe great thanks to the President, Speaker Pelosi, Majority Leader Reid and their leadership teams.
Codexis, Inc., a developer of industrial enzymes to enable the cost advantaged production of biofuels, bio-based chemicals, and pharmaceutical intermediates, today announced that the FDA has approved a new process co-developed by Codexis for the manufacture of sitagliptin, the active pharmaceutical ingredient in Merck's Januvia.
Diabetes prevalence is highest in the Southern and Appalachian states and lowest in the Midwest and the Northeast of America. Researchers writing in BioMed Central's open access journal Population Health Metrics have used two public data sources to investigate the prevalence of diagnosed and undiagnosed diabetes mellitus at the State level.
Results of a new study by neuroscientists at the University of Massachusetts Amherst and the University of Toronto suggest that a new treatment approach is needed - and how this may be possible - to address adverse effects of aromatase inhibitors, drugs commonly prescribed to both men and women to prevent recurrence of estrogen-positive breast cancer.
› Verified 7 days ago
Mr. Franklin Petesch Davison, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 640 Market Street, Colusa, CA 95932 Phone: 530-458-2188 Fax: 530-458-7780 | |
Indarjit Kaur Sidhu, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1021 Bridge St, Colusa, CA 95932 Phone: 530-458-2494 | |
Dr. Charles Thomas Mills, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 452 Market St, Colusa, CA 95932 Phone: 530-902-3356 | |
Mr. Ashak Fakous Botros, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1021 Bridge St, Colusa, CA 95932 Phone: 530-458-2494 Fax: 858-412-4306 | |
Jaskarn Dhaliwal, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1021 Bridge St, Colusa, CA 95932 Phone: 530-458-7325 | |
Vy Nguyen, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1021 Bridge St, Colusa, CA 95932 Phone: 530-458-2494 |